Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
Abstract: The incidence of acute myeloid leukemia (AML) increases with age. Intensive induction chemotherapy containing cytarabine and an anthracycline has been part of the upfront and salvage treatment of AML for decades. Anthracyclines are associated with a significant risk of cardiotoxicity (espe...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 25, 2020
|
| In: |
Blood advances
Year: 2020, Jahrgang: 4, Heft: 4, Pages: 762-775 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2019000955 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1182/bloodadvances.2019000955 Verlag, kostenfrei, Volltext: https://ashpublications.org/bloodadvances/article/4/4/762/452554/Anthracycline-related-cardiotoxicity-in-older 
|
| Verfasserangaben: | Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, Konstantinos Christofyllakis, Wee-Kheng Soo, Bediha Bölükbasi, Carlos Oñoro-Algar, William G. Hundley, and Heidi D. Klepin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693508206 | ||
| 003 | DE-627 | ||
| 005 | 20230427033656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200330s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2019000955 |2 doi | |
| 035 | |a (DE-627)1693508206 | ||
| 035 | |a (DE-599)KXP1693508206 | ||
| 035 | |a (OCoLC)1264299027 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Neuendorff, Nina Rosa |e VerfasserIn |0 (DE-588)119875334X |0 (DE-627)1680932179 |4 aut | |
| 245 | 1 | 0 | |a Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia |b a Young SIOG review paper |c Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, Konstantinos Christofyllakis, Wee-Kheng Soo, Bediha Bölükbasi, Carlos Oñoro-Algar, William G. Hundley, and Heidi D. Klepin |
| 264 | 1 | |c February 25, 2020 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.03.2020 | ||
| 520 | |a Abstract: The incidence of acute myeloid leukemia (AML) increases with age. Intensive induction chemotherapy containing cytarabine and an anthracycline has been part of the upfront and salvage treatment of AML for decades. Anthracyclines are associated with a significant risk of cardiotoxicity (especially anthracycline-related left ventricular dysfunction [ARLVD]). In the older adult population, the higher prevalence of cardiac comorbidities and risk factors may further increase the risk of ARLVD. In this article of the Young International Society of Geriatric Oncology group, we review the prevalence of ARLVD in patients with AML and factors predisposing to ARLVD, focusing on older adults when possible. In addition, we review the assessment of cardiac function and management of ARLVD during and after treatment. It is worth noting that only a minority of clinical trials focus on alternative treatment strategies in patients with mildly declined left ventricular ejection fraction or at a high risk for ARLVD. The limited evidence for preventive strategies to ameliorate ARLVD and alternative strategies to anthracycline use in the setting of cardiac comorbidities are discussed. Based on extrapolation of findings from younger adults and nonrandomized trials, we recommend a comprehensive baseline evaluation of cardiac function by imaging, cardiac risk factors, and symptoms to risk stratify for ARLVD. Anthracyclines remain an appropriate choice for induction although careful risk-stratification based on cardiac disease, risk factors, and predicted chemotherapy-response are warranted. In case of declined left ventricular ejection fraction, alternative strategies should be considered. | ||
| 700 | 1 | |a Loh, Kah Poh |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mims, Alice S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Christofyllakis, Konstantinos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Soo, Wee-Kheng |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bölükbasi, Bediha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oñoro-Algar, Carlos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hundley, William G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klepin, Heidi D. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d Washington, DC : American Society of Hematology, 2016 |g 4(2020), 4, Seite 762-775 |h Online-Ressource |w (DE-627)873588312 |w (DE-600)2876449-3 |w (DE-576)48043249X |x 2473-9537 |7 nnas |a Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia a Young SIOG review paper |
| 773 | 1 | 8 | |g volume:4 |g year:2020 |g number:4 |g pages:762-775 |g extent:14 |a Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia a Young SIOG review paper |
| 856 | 4 | 0 | |u https://doi.org/10.1182/bloodadvances.2019000955 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://ashpublications.org/bloodadvances/article/4/4/762/452554/Anthracycline-related-cardiotoxicity-in-older |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200330 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 119875334X |a Neuendorff, Nina Rosa |m 119875334X:Neuendorff, Nina Rosa |d 910000 |d 910100 |e 910000PN119875334X |e 910100PN119875334X |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1693508206 |e 3615735676 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"14 S."}],"relHost":[{"name":{"displayForm":["American Society of Hematology"]},"origin":[{"dateIssuedDisp":"[2016]-","publisher":"American Society of Hematology","publisherPlace":"Washington, DC"}],"id":{"issn":["2473-9537"],"eki":["873588312"],"zdb":["2876449-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Blood advances","title_sort":"Blood advances"}],"note":["Gesehen am 27.04.21"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia a Young SIOG review paperBlood advances","recId":"873588312","language":["eng"],"pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"part":{"extent":"14","volume":"4","text":"4(2020), 4, Seite 762-775","issue":"4","pages":"762-775","year":"2020"}}],"name":{"displayForm":["Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, Konstantinos Christofyllakis, Wee-Kheng Soo, Bediha Bölükbasi, Carlos Oñoro-Algar, William G. Hundley, and Heidi D. Klepin"]},"origin":[{"dateIssuedDisp":"February 25, 2020","dateIssuedKey":"2020"}],"id":{"eki":["1693508206"],"doi":["10.1182/bloodadvances.2019000955"]},"note":["Gesehen am 30.03.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1693508206","language":["eng"],"person":[{"family":"Neuendorff","given":"Nina Rosa","display":"Neuendorff, Nina Rosa","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Kah Poh","family":"Loh","role":"aut","display":"Loh, Kah Poh","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Mims, Alice S.","role":"aut","family":"Mims","given":"Alice S."},{"given":"Konstantinos","family":"Christofyllakis","role":"aut","roleDisplay":"VerfasserIn","display":"Christofyllakis, Konstantinos"},{"family":"Soo","given":"Wee-Kheng","roleDisplay":"VerfasserIn","display":"Soo, Wee-Kheng","role":"aut"},{"given":"Bediha","family":"Bölükbasi","role":"aut","roleDisplay":"VerfasserIn","display":"Bölükbasi, Bediha"},{"role":"aut","display":"Oñoro-Algar, Carlos","roleDisplay":"VerfasserIn","given":"Carlos","family":"Oñoro-Algar"},{"given":"William G.","family":"Hundley","role":"aut","display":"Hundley, William G.","roleDisplay":"VerfasserIn"},{"given":"Heidi D.","family":"Klepin","role":"aut","roleDisplay":"VerfasserIn","display":"Klepin, Heidi D."}],"title":[{"subtitle":"a Young SIOG review paper","title":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia","title_sort":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia"}]} | ||
| SRT | |a NEUENDORFFANTHRACYCL2520 | ||